Especially, melatonin in breast cancer was known to suppress the estrogen signaling pathway and vascular endothelial growth factor (VEGF)   [11] as well as inhibit aromatase expression and activity [12] in MCF-7 cells. The gene discussed is VEGFA; the disease is breast carcinoma.